This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany
by Zacks Equity Research
DexCom gains 5.6% after announcing plans to launch Dexcom Flex in Germany, expanding CGM access for Type 2 diabetes patients using basal insulin or oral meds.
ISRGPositive Net Change DXCMPositive Net Change WSTPositive Net Change GMEDNegative Net Change
medical medical-devices
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
by Zacks Equity Research
ANGO gains momentum as NanoKnife adoption, strong Med Tech growth and positive clinical trends support its long-term outlook.
ANGONegative Net Change ISRGPositive Net Change CAHNegative Net Change WSTPositive Net Change
medical medical-devices
After Golden Cross, Extreme Networks (EXTR)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
EXTRPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Electromed, Inc. (ELMD)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ELMDNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is This the Right Time to Hold DGX Stock in Your Portfolio?
by Zacks Equity Research
Quest Diagnostics gains from DIS growth, advanced diagnostics uptake and AI-driven efficiencies, though debt levels and healthcare reimbursement risks remain concerns.
DGXNegative Net Change ALGNPositive Net Change GMEDNegative Net Change PAHCNegative Net Change
medical medical-devices
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy
by Zacks Equity Research
CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.
ISRGPositive Net Change CAHNegative Net Change WSTPositive Net Change CVRXNegative Net Change
medical medical-devices
NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer
by Zacks Equity Research
Natera wins FDA approval for Signatera CDx in bladder cancer, marking the first blood-based MRD companion diagnostic milestone.
ISRGPositive Net Change WSTPositive Net Change GMEDNegative Net Change NTRAPositive Net Change
medical medical-devices
Zacks.com featured highlights include Healthcare Services, Electromed, UMB Financial, Shell and MACOM Technology Solutions
by Zacks Equity Research
Healthcare Services, Electromed, UMB Financial, Shell and MACOM Technology Solutions stand out for strong efficiency metrics.
ELMDNegative Net Change UMBFNegative Net Change MTSINegative Net Change HCSGNegative Net Change SHELPositive Net Change
business-services finance medical-devices oil-energy semiconductor
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?
by Moumi Mondal
Abbott vs. Zimmer Biomet: surgical equipment stocks face diverging growth, acquisitions, and valuation shifts as investors weigh momentum and margins.
ABTNegative Net Change ZBHNegative Net Change
medical medical-devices
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
by Zacks Equity Research
Doximity teams with Aledade to bring AI-powered documentation and clinical search tools into physician workflows and value-based care settings.
ISRGPositive Net Change WSTPositive Net Change GMEDNegative Net Change DOCSPositive Net Change
medical medical-devices